Publications by authors named "Solomon Woldu"

Claim this Profile
T
Twelve-Month Results From the CISTO Study Comparing Radical Cystectomy Versus Bladder-Sparing Therapy for Recurrent High-Grade Non-Muscle-Invasive Bladder Cancer.
John L Gore, Erika M Wolff, Michael G Nash, Bryan A Comstock, Scott M Gilbert, Solomon L Woldu

J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiomic Profiling of Tumor Thrombus for Predicting Recurrence in Renal Cell Carcinoma.
Zine-Eddine Khene, Isamu Tachibana, Raj Bhanvadia, Ivan Trevino, Prajwal Sharma, Solomon L Woldu

Eur Urol Open Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in α-Blockade Practices Between Endocrine and Surgical Specialties for Pheochromocytoma and Paraganglioma Resection: A Single-Center Retrospective Study.
Jorge E Mosquera, Shubham Agarwal, Megan Maxwell, Trent Bryson, Mishal Johny, Solomon Woldu

Endocr Pract· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Features and Actionable Gene Targets of Testicular Germ Cell Tumors in a Real-World Setting.
Rafael Morales-Grimany, Krinio Giannikou, Cesar Delgado, Kshitij Pandit, Fady Baky, Solomon Woldu

Int J Mol Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding the hospital safety net Hospital resource limitations impact prostate cancer treatment beyond socioeconomic disparities.
Raj R Bhanvadia, Rohit R Badia, Fady J Baky, Jennifer W Tse, Yair Lotan, Solomon L Woldu

Can Urol Assoc J· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durability of response of UGN-101: Longitudinal follow up of multicenter study.
Solomon L Woldu, Daniel Igel, Brett Johnson, Katie S Murray, Hiroko Miyagi

Urol Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine vs Bacillus Calmette-Guérin for Intravesical Therapy in Treatment-Naïve Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer.
Zine-Eddine Khene, Raj Bhanvadia, Sarah Attia, Willian Ito, Ivan Trevino, Solomon L Woldu

J Urol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of baseline PD-L1 status in BCG naive nonmuscle invasive bladder cancer on outcomes and changes after BCG exposure.
Thomas Gerald, Solomon L Woldu, Daniel Halstuch, Yaara Ber, Karin Lifshitz

Urol Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Tumor Stage on Oncologic Outcomes of High-grade Bacillus Calmette-Guérin Unresponsive Non-muscle-invasive Bladder Cancer Undergoing Bladder-sparing Therapies.
Drupad Annapureddy, Jacob I Taylor, Ashish M Kamat, Michael A O'Donnell, Jeffrey Howard, Solomon L Woldu

Eur Urol Focus· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncologic Outcomes of Sequential Intravesical Gemcitabine and Docetaxel Compared with Bacillus Calmette-Guérin in Patients with Bacillus Calmette-Guérin-Unresponsive Non-Muscle Invasive Bladder Cancer.
Jacob Taylor, Ashish M Kamat, Drupad Annapureddy, Zine-Eddine Khene, Jeffrey Howard, Solomon L Woldu

Eur Urol Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical Outcomes of Radical Nephrectomy and Inferior Vena Cava Thrombectomy Following Preoperative Systemic Immunotherapy: A Propensity Score Analysis.
Zine-Eddine Khene, Raj Bhanvadia, Isamu Tachibana, Wadih Issa, William Graber, Solomon L Woldu

Clin Genitourin Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial Comment.
Yair Lotan, Solomon Woldu

J Urol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes of bladder-sparing therapy vs radical cystectomy in BCG-unresponsive non-muscle-invasive bladder cancer.
Jacob I Taylor, Ashish M Kamat, Michael A O'Donnell, Drupad Annapureddy, Jeffrey Howard, Solomon L Woldu

BJU Int· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting Response to Intravesical Bacillus Calmette-Guérin in High-Risk Nonmuscle-Invasive Bladder Cancer Using an Artificial Intelligence-Powered Pathology Assay: Development and Validation in an International 12-Center Cohort.
Yair Lotan, Viswesh Krishna, Waleed M Abuzeid, Bryn Launer, Sam S Chang, Solomon Woldu

J Urol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refinement of Risk Stratification Is Important for Guiding Treatment and Surveillance Recommendations.
Solomon L Woldu, Yair Lotan

Eur Urol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Socioeconomic and Demographic Disparities in Immunotherapy Utilization for Advanced Kidney and Bladder Cancer.
Levi Holland, Raj Bhanvadia, Nathanaelle Ibeziako, Jacob Taylor, Deitrich Gerlt, Solomon Woldu

Urol Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathological Response and Outcomes in Patients With Metastatic Renal Cell Carcinoma (mRCC) Receiving Immunotherapy-Based Therapies and Undergoing Deferred Cytoreductive Nephrectomy (CN).
Damla Gunenc, Wadih Issa, Thomas Gerald, Qinhan Zhou, Song Zhang, Solomon Woldu

Clin Genitourin Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitochondrial complex I promotes kidney cancer metastasis.
Divya Bezwada, Luigi Perelli, Nicholas P Lesner, Ling Cai, Bailey Brooks, Solomon Woldu

Nature· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardization of the evaluation and surveillance of patients with BCG unresponsive high grade non-muscle invasive bladder cancer clinical trials.
Yair Lotan, Piyush Agarwal, Peter Black, Rian Dickstein, Ashish M Kamat, Solomon Woldu

Urol Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of pathologic features on local recurrence in penile squamous cell carcinoma after penectomy.
Thomas Gerald, Eshan Joshi, Samuel A Gold, Solomon L Woldu, Xiaosong Meng

Surg Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Khurshid R. Ghani's letter to editor regarding the article "Early experience with UGN-101 for the treatment of upper tract urothelial cancer: a multicenter evaluation of practice patterns and outcomes".
Solomon Woldu, Yair Lotan

Urol Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First analysis of the safety and efficacy of UGN-101 in the treatment of ureteral tumors.
Joseph M Jacob, Solomon L Woldu, Jennifer Linehan, Craig Labbate, Kyle M Rose

Urol Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Route of Administration for UGN-101 and Impact on Oncological and Safety Outcomes" [Eur. Urol. Focus (2023)].
Jennifer Linehan, Josh Gottlieb, Solomon L Woldu, Craig Labbate, Kyle Rose

Eur Urol Focus· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Organ sparing treatment for penile cancer using a 3D-printed high-dose-rate brachytherapy applicator.
Hugh H C Lee, Tsuicheng D Chiu, Brian Hrycushko, Zhenyu Xiong, Steve Hudak, Solomon Woldu

Brachytherapy· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Socioeconomic determinants of racial disparities in survival outcomes among patients with renal cell carcinoma.
Ridwan Alam, Michael E Rezaee, Maximilian Pallauf, Roy Elias, Anirudh Yerrapragada, Solomon L Woldu

Urol Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis